TOX3 Mutations in Breast Cancer
暂无分享,去创建一个
Carlos Caldas | James O. Jones | Suet-Feung Chin | Ana-Teresa Maia | B. Ponder | S. Chin | C. Caldas | Ana-Teresa Maia | James Owain Jones | Li-An Wong-Taylor | Donna Leaford | Bruce A. J. Ponder | Donna Leaford | L. Wong-Taylor
[1] Liam J. McGuffin,et al. Protein structure prediction servers at University College London , 2005, Nucleic Acids Res..
[2] S. Tavaré,et al. High-resolution aCGH and expression profiling identifies a novel genomic subtype of ER negative breast cancer , 2007, Genome Biology.
[3] Carlos Caldas,et al. Fine scale mapping of the breast cancer 16q12 locus. , 2010, Human molecular genetics.
[4] Gabriella Siszler,et al. TOX3 is a neuronal survival factor that induces transcription depending on the presence of CITED1 or phosphorylated CREB in the transcriptionally active complex , 2011, Journal of Cell Science.
[5] C. Béroud,et al. Human Splicing Finder: an online bioinformatics tool to predict splicing signals , 2009, Nucleic acids research.
[6] Christian A. Rees,et al. Molecular portraits of human breast tumours , 2000, Nature.
[7] Mingming Jia,et al. COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer , 2010, Nucleic Acids Res..
[8] Swneke D. Bailey,et al. Breast cancer risk-associated SNPs modulate the affinity of chromatin for FOXA1 and alter gene expression , 2012, Nature Genetics.
[9] Y. Drouet,et al. Mutational characterization of individual breast tumors: TP53 and PI3K pathway genes are frequently and distinctively mutated in different subtypes , 2012, Breast Cancer Research and Treatment.
[10] Steven Henikoff,et al. SIFT: predicting amino acid changes that affect protein function , 2003, Nucleic Acids Res..
[11] R. Tibshirani,et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[12] F. Marincola,et al. TNRC9 downregulates BRCA1 expression and promotes breast cancer aggressiveness. , 2013, Cancer research.
[13] B. Agnarsson,et al. The risk allele of SNP rs3803662 and the mRNA level of its closest genes TOX3 and LOC643714predict adverse outcome for breast cancer patients , 2012, BMC Cancer.
[14] Lester L. Peters,et al. Genome-wide association study identifies novel breast cancer susceptibility loci , 2007, Nature.
[15] I. Ellis,et al. A gene-expression signature to predict survival in breast cancer across independent data sets , 2007, Oncogene.
[16] Anirvan Ghosh,et al. Tox3 Regulates Calcium-dependent Transcription in Neurons We Report the Cloning and Characterization of Tox3, a High Mobility Group Box Protein Involved in Mediating Calcium-dependent Tran- Scription. Tox3 Was Identified as a Calcium-dependent Transactivator Using the Transactivator Trap Screen. We , 2022 .
[17] B. Ponder,et al. Extent of differential allelic expression of candidate breast cancer genes is similar in blood and breast , 2009, Breast Cancer Research.
[18] J. Kaye,et al. TOX defines a conserved subfamily of HMG-box proteins , 2003, BMC Genomics.
[19] H. Lehrach,et al. An efficient and economic enhancer mix for PCR. , 2006, Biochemical and biophysical research communications.
[20] D. Gudbjartsson,et al. Common variants on chromosomes 2q35 and 16q12 confer susceptibility to estrogen receptor–positive breast cancer , 2007, Nature Genetics.